Publications

• Industry opposes genomic legislation. Nature Biotechnology, May;20: 419 (2002). Published, 05/2002.
• Amgen preserves erythropoietin monopoly for now. Nature Biotechnology, Mar;19: 188 (2001). Published, 03/2001.
• Hatch-Waxman changes debated. Nature Biotechnology, Jul;18: 710-1(2000). Published, 07/2000.
• Amgen battles for EPO in Congress. Nature Biotechnology, Nov;16:999-1000 (1998). Published, 11/1998.
• The importance of "legalese" in biotechnology patents. Nature Biotechnology, Oct;16: 971-2(1998). Published, 10/16/1998.
• Building the proper foundation for genomic based patents, Nature Biotechnology, 16: 683-684 (1998). Published, 07/1998.
• Cancer prognostic approved. Nature Biotechnology, Feb;16:121(1998). Published, 02/1998.
• All clear for HIV-targeting ribozyme in phase II. Nature Biotechnology, Feb;16:123(1998). Published, 02/1998.
• Elanex battles for piece of erythropoietin market, Nature Biotechnology, 16: 16 (1998). Published, 01/1998.
• US courts disagree on generic exclusivity, Nature Biotechnology, 16: 132 (1998). Published, 01/1998.
• Patent office resurrects EST debate, Nature Biotechnology, 16: 711 (1998). Published, 01/1998.
• Genentech sues to protect clot buster market share, Nature Biotechnology, 16: 410 (1998). Published, 01/1998.
• Enabling DNA and Protein Claims: Why Claiming Biological Equivalents Encourages Innovation, American Intellectual Property Law Association Quarterly Journal, 25(3): 333 (1997). Published, 01/1997.
• Amgen Protects its Billion Dollar Protein, Nature Biotechnology, 15: 496-497 (1997). Published, 01/1997.
• Patenting Genes: Just when you thought it was safe, Nature Biotechnology, 15: 586-587 (1997). Published, 01/1997.
• An Industry in Focus: Utah's Biotechnology Boom, Utah Business, October: 27-31 (1997). Published, 01/1997.
• Wrangling over the rights to BRAC1, Nature Biotechnology, 15: 936 (1997). Published, 01/1997.
• Eli Lilly Wins on Appeal, Nature Biotechnology, 15: 823 (1997). Published, 01/1997.
• University of Colorado wins inventorship dispute with American Cyanamid, Nature Biotechnology, 15: 831 (1997). Published, 01/1997.
• Going beyond the native: Protecting DNA and protein patents, Nature Biotechnology, 15: 183-185 (1997). Published, 01/1997.
• Electrical Activity Suppresses Nicotinic Acetylcholine Receptor Gamma Subunit Promoter Activity. Developmental Biology, 168: 416-428 (1995). Published, 01/1995.
• Calcium Regulates the Expression of the Nicotinic Acetylcholine Receptor Subunit RNAs, Journal of Biological Chemistry, 269: 19447-19456, (1994). Published, 01/1994.
• Coupling Muscle Electrical Activity to Nicotinic Acetylcholine Receptor Gene Expression Via a Cyclic AMP-Dependent Second Messenger System, Journal of Biological Chemistry, 268, 2893-2898, (1993). Published, 01/1993.
• A 102 Base Pair Sequence Confers Electrical Regulation on the Nicotinic Acetylcholine Receptor (nAChR) Delta-Subunit, Development, 12 , 123-128, (1992). Published, 01/1992.
• Molecular and electrophysiological characterization of the allelic variant of the rat alpha-6 GABA-A receptor subunit, Molecular Brain Research, 16, 173-178, (1992). Published, 01/1992.